Do high-risk features support the use of adjuvant chemotherapy in stage II colon cancer? A Turkish Oncology Group study

ARTAÇ M., Turha N. S., Kocer M., KARABULUT B., Bozcuk H., Yalcin S., ...Daha Fazla

TUMORI JOURNAL, cilt.100, sa.2, ss.143-148, 2014 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 100 Sayı: 2
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1700/1491.16397
  • Dergi Adı: TUMORI JOURNAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.143-148
  • Anahtar Kelimeler: colon cancer, adjuvant therapy, prognostic factors, COLORECTAL-CANCER, FLUOROURACIL, OXALIPLATIN, LEUCOVORIN, THERAPY, SURVIVAL, OUTCOMES
  • Kocaeli Üniversitesi Adresli: Evet

Özet

Background. A high-risk group of patients with stage II colon cancer has been identified by the results of studies in Western populations. The aim of this study was to investigate the prognostic factors of adjuvant chemotherapy in Turkish patients with stage II colon cancer.